300 related articles for article (PubMed ID: 9002740)
21. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
[TBL] [Abstract][Full Text] [Related]
22. Localization of a pheochromocytoma using I-123 MIBG adrenal scintigraphy.
Shirkare S; Kuwert T; Weckesser M; Czech N; Langen KJ; Muller-Gartner HW
J Postgrad Med; 1994; 40(2):85-7. PubMed ID: 8737560
[TBL] [Abstract][Full Text] [Related]
23. Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues.
Wiseman GA; Kvols LK
Semin Nucl Med; 1995 Jul; 25(3):272-8. PubMed ID: 7570046
[TBL] [Abstract][Full Text] [Related]
24. Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT.
Nielsen JT; Nielsen BV; Rehling M
Clin Nucl Med; 1996 Sep; 21(9):695-9. PubMed ID: 8879869
[TBL] [Abstract][Full Text] [Related]
25. The evolution in the use of MIBG scintigraphy in pheochromocytomas and paragangliomas.
Rufini V; Treglia G; Perotti G; Giordano A
Hormones (Athens); 2013; 12(1):58-68. PubMed ID: 23624132
[TBL] [Abstract][Full Text] [Related]
26. [Scintigraphic imaging of benign and malignant tumors of the sympathetic nervous system with meta-iodobenzylguanidine].
Kimmig B; Brandeis WE; Eisenhut M; Bubeck B; Georgi P
Rontgenblatter; 1985 May; 38(5):154-8. PubMed ID: 4012198
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
Troncone L; Rufini V; Montemaggi P; Danza FM; Lasorella A; Mastrangelo R
Eur J Nucl Med; 1990; 16(4-6):325-35. PubMed ID: 2351179
[TBL] [Abstract][Full Text] [Related]
28. Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors.
McEwan AJ; Shapiro B; Sisson JC; Beierwaltes WH; Ackery DM
Semin Nucl Med; 1985 Apr; 15(2):132-53. PubMed ID: 3890187
[TBL] [Abstract][Full Text] [Related]
29. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
Fischer M
Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
[TBL] [Abstract][Full Text] [Related]
30. Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging.
Havekes B; Lai EW; Corssmit EP; Romijn JA; Timmers HJ; Pacak K
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):419-29. PubMed ID: 19088695
[TBL] [Abstract][Full Text] [Related]
31. [Pre- and intraoperative localization of neuroendocrine tumors].
Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
[TBL] [Abstract][Full Text] [Related]
32. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
Nakajo M; Shinohara S
Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
[No Abstract] [Full Text] [Related]
33. 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Minn H; Kemppainen J; Kauhanen S; Forsback S; Seppänen M
PET Clin; 2014 Jan; 9(1):27-36. PubMed ID: 25029931
[TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and therapy of neuroectodermal tumors].
Adolph J; Kimmig B
Radiologe; 1989 Jan; 29(1):32-42. PubMed ID: 2537501
[TBL] [Abstract][Full Text] [Related]
35. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
Shapiro B
Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
[TBL] [Abstract][Full Text] [Related]
36. Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.
Gelfand MJ; Elgazzar AH; Kriss VM; Masters PR; Golsch GJ
J Nucl Med; 1994 Nov; 35(11):1753-7. PubMed ID: 7965151
[TBL] [Abstract][Full Text] [Related]
37. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C
J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058
[TBL] [Abstract][Full Text] [Related]
38. [Iodine-131 meta-iodobenzylguanidine for the diagnosis and treatment of pheochromocytoma and tumors of neural crest origin].
Horne T
Harefuah; 1992 Apr; 122(8):526-9. PubMed ID: 1398325
[No Abstract] [Full Text] [Related]
39. [Possibility of using 131I-meta-iodobenzylguanidine in the diagnosis of neuroendocrine tumors differing from pheochromocytomas].
Troncone L; Rufini V; Maini CL; Valenza V; Danza FM; Lasorella A
Radiol Med; 1986 Dec; 72(12):963-8. PubMed ID: 3797720
[TBL] [Abstract][Full Text] [Related]
40. Radioiodinated iodobenzylguanidines for diagnosis and therapy.
McEwan AJ; Wyeth P; Ackery D
Int J Rad Appl Instrum A; 1986; 37(8):765-75. PubMed ID: 3021678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
